Teratocarcinoma and Embryonic Cell Interactions.
(Eds. T. MURAMATSU, G. GACHELIN, A. A. MOSCONA and Y. IKAWA) UK, Academic Press, Inc, 344 pp, 1982, £23.80. We are living in the golden age of molecular and cellular biology. New discoveries assail us from the pages of "learned" journals and are often published first in the daily newspapers. At such a time two years is a long period to wait for a meeting report which summarises an area of active research. The editors have attempted to ameliorate this problem by writing a summary of the advances made in teratocarcinoma research between 1980 and the publication date. Unfortunately, this serves to emphasise the problem and increases the introduction section of the book to the record proportions of two Forewords, a Preface and two Editorial Notes.
Teratocarcinomas are a focal point where tumour biology and developmental biology meet. This confluence has contributed much to concepts in tumour biology and is currently apparent in the study of high molecular weight carbohydrate structures found on murine embryos and teratocarcinoma stem cells and on many human tumour cells. The clustering of related papers on the same topic is one of the advantages that a meeting report has compared with conventional publication and the editors are to be congratulated on their prescience in selecting carbohydrate biochemistry as a major theme of their meeting. Another advantage the meeting report has over journal publication is the possibility of including discussion of presented papers. These sections in the book make exciting reading being, apparently, faithful transcripts even down to the theatrical gestures of the speakers. In The selection of subject matter is rather quirky. There are two chapters on the use and relevance of short-term tests for detecting mutagens in food (Sugimura and Nago; Stich, et al.) but nothing on the use of mutagenicity tests for looking for endogenous mutagens in body fluids and excretasurely a "new horizon" and fascinating if only for the enormous problems attendant upon such studies. A chapter on the use of short-term tests for monitoring water supplies is also lacking.
The book starts with John Ashby's stimulating views on the value of short-term tests for predicting long-term effects such as carcinogenicity. In the preface, the Editor (John Heddle) alludes to the "explosive growth" in this area, and in one respect, Ashby has been caught in the blast. He dwells upon the challenge to genotoxicology posed by the inability of ethylene oxide (a potent, directly-acting alkylating mutagen) to induce tumours at the site of application-the respiratory tract of animals dosed by inhalation. This is an unusual finding for a directly-acting alkylating agent. He makes much of tumours (testicular mesotheliomas) which arose remote from the application site, and suggests that the bacterial mutagenicity of ethylene oxide resides in the activity of the parent molecule, and that the "indirect" carcinogenic effect in mammals may be due to a metabolite: this may be so. However, like the unfortunate Richard III, Ashby runs before his horse to market, since ethylene oxide does induce tumours at the site of application. Dunkelberg (Br. J. Cancer, 46: 924, 1982) force-fed rats with it and produced squamous-cell carcinomas of the forestomach. Even after 3 years, this treatment did not induce tumours remote from the application site. This illustrates the dangers of over-interpreting short-term data (which are easy to collect and therefore plentiful) and using them to erect elaborate hypotheses to explain scarce and sometimes dubious data from long-term experiments. However, Ashby has done us a service by airing these problems.
There It is divided into eight major sections. The first comprises four review articles which provide an excellent introduction to the metabolism and pharmacology of the prostaglandins. The remaining sections are each divided into review papers and brief reports. Many of the latter are so insubstantial as to only add to the bulk of an overlong book without adding significantly to its value.
The second and third sections cover respectively, the initiation and promotion phases of carcinogenesis. The former provides in-depth reviews on the role of prostaglandin oxygenases in the synthesis of carcinogenic metabolites, whilst the latter is concerned with the actual role that the prostaglandins may play in tumour promotion.
The next two sections concern the role of prostaglandins in the control of cell replication/proliferation and cell differentiation/interaction. These are followed by a section entitled Prostaglandins, bone metastases and hypercalcaemia which closely relates to the following section covering host-tumour interactions. These two sections attempt to integrate the relationship and relative roles of prostaglandins synthesised by the tumour cell and the host during tumour progression.
The concluding section, covering the effect of pharmacological manipulation of prostaglandin synthesis on tumour growth and metastasis in vivo, describes potential applications to the treatment of cancer. The final paper in this section describes the sole human study and concludes on the depressing note that the infusion of prostaglandins known to inhibit tumour cell proliferation in experimental systems has no effect on the progression of human cancer. This disappointing result is in contrast to the work described elsewhere in this book, which covers an exciting interaction between two areas of scientific research.
Specialists in the field of prostaglandin research will probably gain little from this book, but those oncologists prepared to delve into its 841 pages will find many papers of interest. 
